TV News LIES

Wednesday, Jul 30th

Last update05:08:45 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Mississippi’s Lone Abortion Clinic Survives Court Appeal

mississippi abortion clinic savedMississippi’s lone abortion clinic will remain open for now, after an appeals court criticized as probably...

Exposing Monsanto: Herbicide Linked to Birth Defects - the Vitamin A Connection

MonsantoMonsanto's herbicide Roundup, with glyphosate as the primary ingredient, has recently been linked to a fatal...

Top Ebola doctor dead in African outbreak; local airline suspends flights

Ebola doctor diesA leading doctor who risked his own life to treat dozens of Ebola patients died Tuesday...

Ebola now taking toll on doctors and other health care workers

Ebola kills doctorAn Ebola outbreak that has killed more than 670 people in Africa is now taking a...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!